
Elli Peselev
Examiner (ID: 18809)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1803, 1211, 1203, 1802, 1621, 1623, 2899 |
| Total Applications | 2819 |
| Issued Applications | 1829 |
| Pending Applications | 143 |
| Abandoned Applications | 853 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 08/290416 | PSYLLIUM DRINK MIX COMPOSITIONS CONTAINING GRANULATED BASE | Aug 14, 1994 | Abandoned |
Array
(
[id] => 3623836
[patent_doc_number] => 05612316
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-18
[patent_title] => 'Fluorosugar derivatives of macrolides'
[patent_app_type] => 1
[patent_app_number] => 8/295625
[patent_app_country] => US
[patent_app_date] => 1994-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10061
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/612/05612316.pdf
[firstpage_image] =>[orig_patent_app_number] => 295625
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/295625 | Fluorosugar derivatives of macrolides | Aug 7, 1994 | Issued |
Array
(
[id] => 3876726
[patent_doc_number] => 05747465
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Sugar derivatives of macrolides'
[patent_app_type] => 1
[patent_app_number] => 8/284504
[patent_app_country] => US
[patent_app_date] => 1994-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9052
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747465.pdf
[firstpage_image] =>[orig_patent_app_number] => 284504
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/284504 | Sugar derivatives of macrolides | Aug 7, 1994 | Issued |
Array
(
[id] => 3634263
[patent_doc_number] => 05631235
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => '2-Aminosugar derivatives of macrolides'
[patent_app_type] => 1
[patent_app_number] => 8/284687
[patent_app_country] => US
[patent_app_date] => 1994-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10258
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631235.pdf
[firstpage_image] =>[orig_patent_app_number] => 284687
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/284687 | 2-Aminosugar derivatives of macrolides | Aug 5, 1994 | Issued |
Array
(
[id] => 3620794
[patent_doc_number] => 05614506
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => 'Use of hyaluronic acid and forms to prevent arterial restenosis'
[patent_app_type] => 1
[patent_app_number] => 8/285764
[patent_app_country] => US
[patent_app_date] => 1994-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5692
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614506.pdf
[firstpage_image] =>[orig_patent_app_number] => 285764
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/285764 | Use of hyaluronic acid and forms to prevent arterial restenosis | Aug 2, 1994 | Issued |
Array
(
[id] => 3602519
[patent_doc_number] => 05578579
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-26
[patent_title] => '4\"-deoxyerythromycin derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/284730
[patent_app_country] => US
[patent_app_date] => 1994-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9398
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/578/05578579.pdf
[firstpage_image] =>[orig_patent_app_number] => 284730
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/284730 | 4"-deoxyerythromycin derivatives | Aug 1, 1994 | Issued |
Array
(
[id] => 3586887
[patent_doc_number] => 05552387
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Polycyclic ether antibiotics'
[patent_app_type] => 1
[patent_app_number] => 8/284874
[patent_app_country] => US
[patent_app_date] => 1994-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3048
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552387.pdf
[firstpage_image] =>[orig_patent_app_number] => 284874
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/284874 | Polycyclic ether antibiotics | Aug 1, 1994 | Issued |
Array
(
[id] => 3657556
[patent_doc_number] => 05658887
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => 'Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivatite'
[patent_app_type] => 1
[patent_app_number] => 8/256675
[patent_app_country] => US
[patent_app_date] => 1994-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 2836
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/658/05658887.pdf
[firstpage_image] =>[orig_patent_app_number] => 256675
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/256675 | Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivatite | Jul 19, 1994 | Issued |
Array
(
[id] => 3551763
[patent_doc_number] => 05573926
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-12
[patent_title] => 'Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained'
[patent_app_type] => 1
[patent_app_number] => 8/276779
[patent_app_country] => US
[patent_app_date] => 1994-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 15486
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/573/05573926.pdf
[firstpage_image] =>[orig_patent_app_number] => 276779
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/276779 | Process for obtaining aroma components and aromas from their precursors of a glycosidic nature, and aroma components and aromas thereby obtained | Jul 17, 1994 | Issued |
Array
(
[id] => 3623112
[patent_doc_number] => 05602106
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => '16-membered macrolide derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/271996
[patent_app_country] => US
[patent_app_date] => 1994-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57754
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602106.pdf
[firstpage_image] =>[orig_patent_app_number] => 271996
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/271996 | 16-membered macrolide derivatives | Jul 7, 1994 | Issued |
| 08/271951 | CHONDROPROTECTIVE AGENTS | Jul 7, 1994 | Abandoned |
Array
(
[id] => 3571323
[patent_doc_number] => 05538954
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-23
[patent_title] => 'Salts of tetracyclines'
[patent_app_type] => 1
[patent_app_number] => 8/265193
[patent_app_country] => US
[patent_app_date] => 1994-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4310
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/538/05538954.pdf
[firstpage_image] =>[orig_patent_app_number] => 265193
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/265193 | Salts of tetracyclines | Jun 23, 1994 | Issued |
Array
(
[id] => 3636215
[patent_doc_number] => 05631354
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => '5-O-desosaminylerythronolide derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/256124
[patent_app_country] => US
[patent_app_date] => 1994-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23751
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631354.pdf
[firstpage_image] =>[orig_patent_app_number] => 256124
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/256124 | 5-O-desosaminylerythronolide derivatives | Jun 20, 1994 | Issued |
Array
(
[id] => 3622174
[patent_doc_number] => 05593970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-14
[patent_title] => 'Heterocyclic anthracycline analogs'
[patent_app_type] => 1
[patent_app_number] => 8/263925
[patent_app_country] => US
[patent_app_date] => 1994-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104555
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 354
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/593/05593970.pdf
[firstpage_image] =>[orig_patent_app_number] => 263925
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/263925 | Heterocyclic anthracycline analogs | Jun 19, 1994 | Issued |
Array
(
[id] => 3576587
[patent_doc_number] => 05523399
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-04
[patent_title] => '5-O-desosaminylerythronolide derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/244981
[patent_app_country] => US
[patent_app_date] => 1994-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5059
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/523/05523399.pdf
[firstpage_image] =>[orig_patent_app_number] => 244981
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/244981 | 5-O-desosaminylerythronolide derivatives | Jun 19, 1994 | Issued |
Array
(
[id] => 3784606
[patent_doc_number] => 05736353
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Assay reagents'
[patent_app_type] => 1
[patent_app_number] => 8/261007
[patent_app_country] => US
[patent_app_date] => 1994-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2249
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736353.pdf
[firstpage_image] =>[orig_patent_app_number] => 261007
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/261007 | Assay reagents | Jun 13, 1994 | Issued |
Array
(
[id] => 3960673
[patent_doc_number] => 05900406
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-04
[patent_title] => 'Use of antibiotics of the type 2-deoxystreptamine substituted with aminosugars to inhibit growth of microorganisms containing group I introns'
[patent_app_type] => 1
[patent_app_number] => 8/255611
[patent_app_country] => US
[patent_app_date] => 1994-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 4191
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/900/05900406.pdf
[firstpage_image] =>[orig_patent_app_number] => 255611
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/255611 | Use of antibiotics of the type 2-deoxystreptamine substituted with aminosugars to inhibit growth of microorganisms containing group I introns | Jun 7, 1994 | Issued |
Array
(
[id] => 3695402
[patent_doc_number] => 05618798
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Use of sucralfate to treat baldness'
[patent_app_type] => 1
[patent_app_number] => 8/247478
[patent_app_country] => US
[patent_app_date] => 1994-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618798.pdf
[firstpage_image] =>[orig_patent_app_number] => 247478
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/247478 | Use of sucralfate to treat baldness | May 22, 1994 | Issued |
Array
(
[id] => 4279346
[patent_doc_number] => 06281342
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Pradimicin compounds'
[patent_app_type] => 1
[patent_app_number] => 8/241837
[patent_app_country] => US
[patent_app_date] => 1994-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6874
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281342.pdf
[firstpage_image] =>[orig_patent_app_number] => 241837
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/241837 | Pradimicin compounds | May 11, 1994 | Issued |
Array
(
[id] => 3693761
[patent_doc_number] => 05679646
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'Solvent for a sparingly soluble gentamicin salt'
[patent_app_type] => 1
[patent_app_number] => 8/238086
[patent_app_country] => US
[patent_app_date] => 1994-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2230
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679646.pdf
[firstpage_image] =>[orig_patent_app_number] => 238086
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/238086 | Solvent for a sparingly soluble gentamicin salt | May 3, 1994 | Issued |